Navigation Links
Improved governance needed to realize nanotech's benefits
Date:4/23/2008

WASHINGTON - Without an improved governance structure, the benefits of nanotechnology may be difficult to fully realize because the public will not trust the cutting-edge technology, says David Rejeski, director of the Project on Emerging Nanotechnologies (PEN). Rejeski testifies on Thursday, April 24, before the Senate subcommittee on technology and innovation.

Public trust is the dark horse in nanotechnologys future, states Rejeski in his testimony. If government and industry do not work to build public confidence in nanotechnology, consumers may reach for the No-Nano label in the future and investors will put their money elsewhere. Public perceptions about risksreal and perceivedcan have large economic impacts. For example, the European Unions ban on genetically modified foods, driven largely by public concerns, cost American farmers an estimated $300 million annually in lost sales and much more in products that never made it to the marketplace.

Congressional lawmakers are currently discussing amendments to and reauthorization of the 21st Century Nanotechnology Research & Development Act, which helps sets the roadmap for the annual $1.5 billion federal spending on nanotechnology research that is vital to ensuring the technologys success.

What: Senate Commerce, Science & Transportation Committee Subcommittee on Science, Technology and Innovation hearing National Nanotechnology Initiative: Charting the Course for Reauthorization

When: April 24, 2008, 2:30 p.m.

Where: Russell Senate Office Building Room 253, Washington, DC

Who: David Rejeski directs the Project on Emerging Nanotechnologies. For the past eight years, he has also been the Director of the Foresight and Governance Project at the Woodrow Wilson Center. He has held various positions at the White House Council on Environmental Quality (CEQ), the White House Office of Science and Technology (OSTP), and the Environmental Protection Agency (EPA). He
'/>"/>

Contact: Alex Parlini
alex.parlini@wilsoncenter.org
301-768-8366
Project on Emerging Nanotechnologies
Source:Eurekalert

Page: 1 2

Related biology technology :

1. New Robotic Imaging Technology Holds Promise of Improved Cancer Care
2. Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer
3. Diagnostic Turnaround Improved by 600% Through Interoperability
4. Improved wettability of carbon nanotubes opens the door to new possibilities
5. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
6. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
7. Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety
8. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
9. Farmers Across the U.S. Realize Double-Digit Yield Advantage From DEKALB(R) Corn Seeds With Triple-Stacked Traits
10. Cord Blood America Says Pennsylvania Joins New York and California in Establishing Educational Programs on the Benefits of Umbilical Cord Blood Storage
11. Study Finds Widespread Vitamin and Mineral Use Among Cancer Survivors, Although Benefits of Such Use Remain Unclear
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014 GenomeDx Biosciences today announced that a ... a genomic test for prostate cancer, was able to ... by radical prostatectomy without adjuvant therapy. Although rapid metastasis ... using tumor genomics to identify these men who have ... important advance. The study has been published online ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Fertility Associates ... Donor Egg Bank USA , a network of more ... Through this partnership, patients have fast access to a ... vitro fertilization, IVF . Fertility Associates of Memphis is ... this fertility treatment option. , Dr. William Kutteh ...
(Date:12/19/2014)... , Dec. 19, 2014 Naurex Inc., ... novel drugs for diseases of the central nervous system, ... and chief executive officer, will present at the 33 ... presentation will take place at 3:00 p.m. PST on ... in San Francisco, Calif. ...
(Date:12/19/2014)... DUBLIN , Dec. 19, 2014 Research ... announced the addition of the "Technology Innovations ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... Innovations in Smart Fabrics" offers a detailed assessment ... Key Findings: 1. ...
Breaking Biology Technology:Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Technology Innovations in Smart Fabrics (Technical Insights) 2
... 25 Peptimmune, Inc., a privately held biotechnology company, ... the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in ... is a novel peptide copolymer for the treatment of ... The Phase Ib multiple-ascending dose, double-blind, placebo-controlled, ...
... ... - An Innovative Treatment for Multiple Sclerosis and Other Autoimmune Diseases , ... New York, NY/Rockville, MD (Vocus) ... the National Multiple Sclerosis Society,s subsidiary devoted to bridging the gap between research and ...
... JERUSALEM, August 25 Oramed Pharmaceuticals,Inc. (OTCBB: ORMP.OB) ... announced that it is the recipient of the 2009 ... , Oramed Pharmaceuticals is developing ... and vaccines delivered via injection. Oramed,focuses on the treatment ...
Cached Biology Technology:Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009 2Peptimmune Completes Phase Ib Study of PI-2301 in Multiple Sclerosis Patients, and Presentation at ECTRIMS 2009 3Fast Forward, LLC and Amplimmune, Inc. Join Forces to Speed New Treatments to People with MS** 2Fast Forward, LLC and Amplimmune, Inc. Join Forces to Speed New Treatments to People with MS** 3Fast Forward, LLC and Amplimmune, Inc. Join Forces to Speed New Treatments to People with MS** 4Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award 2Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award 3
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
(Date:12/17/2014)... NEW YORK , Dec. 15, 2014 /PRNewswire-USNewswire/ ... a Good Clinical Practices (GCP) audit to confirm ... Administration (FDA) regulations. This accomplishment enables HITLAB to ... trials utilizing the highest principles for patient safety ... to improve global healthcare access, quality, and delivery ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... that children smash to stain their cheeks purple-red and that ... be the key to spreading solar power across the globe, ... and Molecular Materials. Nanotech Center scientists have used the ... inexpensive fiber-based solar cells. The dye acts as an absorber, ...
... is available in German . 48 healthy males ... the start of the experiment, the other half a placebo. The ... in the form of a crying child, a girl hugging her ... to express the depth of feeling they experienced for the persons ...
... - Veterinary vision scientists at the University of Pennsylvania have ... class of photoreceptors of the retina called rods, a critical ... by rod degeneration. In this study, the ... to correct a DNA mutation, was not intended to treat ...
Cached Biology News:Purple Pokeberries hold secret to affordable solar power worldwide 2Hormone spray improves male sensitivity 2Gene therapy sets stage for new treatments for inherited blindness, Penn veterinary researchers say 2
Kinase Buffer can be used to assay protein kinase activity...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: